Recently, it was shown that TNFR-1 (TNF receptor 1) knockout mice were protected from 2,8-DHA nephropathy, suggesting that TNFR1 antagonism could be a potential future target for APRT deficiency in human [44]. Here, TNFRSF1A is linked to Nephropathy.